China National Medicines (SHSE:600511) Other Long-Term Liabilities : ¥834 Mil (As of Mar. 2025)

View and export this data going back to 2002. Start your Free Trial

What is China National Medicines Other Long-Term Liabilities?

China National Medicines's other long-term liabilities for the quarter that ended in Mar. 2025 was ¥834 Mil.

China National Medicines's quarterly other long-term liabilities declined from Sep. 2024 (¥970 Mil) to Dec. 2024 (¥837 Mil) and declined from Dec. 2024 (¥837 Mil) to Mar. 2025 (¥834 Mil).

China National Medicines's annual other long-term liabilities declined from Dec. 2022 (¥827 Mil) to Dec. 2023 (¥820 Mil) but then increased from Dec. 2023 (¥820 Mil) to Dec. 2024 (¥837 Mil).

China National Medicines Other Long-Term Liabilities Historical Data

The historical data trend for China National Medicines's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Medicines Other Long-Term Liabilities Chart

China National Medicines Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

312.99

717.85

826.96

819.97

836.53

China National Medicines Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															882.64	969.28	969.52	836.53	834.36

China National Medicines Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

China National Medicines Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of China National Medicines's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Xibinhe Road, Floor 6-9, West Tower, 7th Floor, Yongdingmen, Dongcheng District, Beijing, CHN, 100077

Website

http://www.cncm.com.cn

China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The Company has one main reportable segment, the Commercial segment, which consists of the operating segment of pharmaceutical sales. Its other reportable segments consist of pharmaceutical production and logistics segments The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics and biochemical drugs.

Executives

Chen Zhang Qing

Director

China National Medicines Headlines

No Headlines